Soleus Capital Management’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-55,500	Closed	-$2.32M	–	97
2024 Q2	$2.32M	Sell	55,500 -102,300	-65%	-$4.29M	0.21%	76
2024 Q1	$5.94M	Buy	+157,800	New	+$5.94M	0.44%	61